ASPHANET | Asphalion´s new service

May 25, 2022

Enhance your Pharmacovigilance and Regulatory Affairs capabilities in EU thanks to ASPHANET!

At Asphalion we are introducing our new service, ASPHANET, a network of qualified partners that allows us to provide pharmacovigilance and regulatory affairs services throughout Europe.

These are some of the several advantages of having a solid EU network:

  • Simplicity and Time optimization: Single point of RA and LPPVs management by Asphalion
  • Trust: Reliable regulatory affairs and PV experts in all EU markets
  • Local presence throughout Europe: knowledge of local regulation and native language
  • Close relationship with local health authorities
  • Improved quality and homogenization in all deliverables and outcome

Have look here at all the detailed services:


Get in touch if you would like to know more about this service:





Search News & Events

  • Filter by category


Related news and events

EVENT | Medicines for Europe annual conference

Asphalion’s Managing Director, Núria Romero, and Lidia Cánovas, Key Accounts Director will be joining the Medicines for Europe annual conference in Malta next week. The

NEW | MHRA announces new recognition routes

MHRA announces new recognition routes to facilitate safe access to new medicines with seven international partners.
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting